Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3113 results found
Expand All
Apply All
3113 results found

BIO joins Gov. Wes Moore at Maryland BioPark
Share
Good Day BIO Newsletter  •  October 11, 2023
BIO CEO Rachel King joined Maryland Gov. Wes Moore at the University of Maryland BioPark yesterday, where Maryland’s innovative bioeconomy was on full display. Meanwhile, good news and bad news on bird flu highlights the need for biotech solutions to address human and animal health. (479 words, 2 minutes, 23 seconds)
Read More

BIO Comments to FDA on Postmarketing Approaches to Obtain Data on Under-Represented Populations in Clinical Trials (FDA-2022-D-2629)
Share
Letters, Testimony & Comments  •  October 10, 2023
In response to their request for information, BIO submitted these comments, including line-by-line recommended edits.
Read More

‘Vulnerable? Vaccinate.’
Share
Good Day BIO Newsletter  •  October 10, 2023
New data highlights the need for the most vulnerable to get updated vaccines, while a growing body of evidence highlights the impact of climate change on our health (and what biotech can do on both fronts). (432 words, 2 minutes, 9 seconds)
Read More

BIO Federal Government Relations Committee Meeting
Share
October 9, 2023
The Federal Government Relations Committee concentrates on educating and lobbying government officials regarding legislative proposals affecting the biotechnology industry. The committee reviews the BIO legislative and regulatory agenda as a whole to set priorities and strategies; initiates BIO policy discussions regarding legislation; and provides advice and recommendations to the Board. Committee members meet with various government officials and their staffs to gain information, offer insight and advice, and buttress BIO positions. The committee collaborates on substance and formulates legislative strategy for major BIO priorities. For more information and to join the Committee, please contact Amanda Galich (agalich@bio.org).
Read More

From harmful carbon to useful products
Share
Good Day BIO Newsletter  •  October 9, 2023
It’s the last week of Hispanic Heritage Month, a chance to look at inequities in health care and how we can overcome them. Plus, how synbio is removing greenhouse gas emissions and creating better products. (512 words, 2 minutes, 33 seconds)
Read More

The future of sickle cell disease
Share
Good Day BIO Newsletter  •  October 6, 2023
BIO Chair Dr. Ted Love won a prestigious award for his commitment to sickle cell disease patients—here’s what he says about the future of treatments. Plus, September heat shattered records, by a record margin—but biotech offers solutions. (456 words, 2 minutes, 16 seconds)
Read More

BIO Office Hours: Pitching to Investors
Share
October 5, 2023
Sharing your company’s vision with potential investors or partners can be a critical factor in growing the company. A pitch deck is an essential tool for communicating your path to success. Ahead of the BIO Investor Forum (BIF) in October, business development expert, Linda Pullan from Pullan Consulting will be hosting twenty-minute virtual appointments to review and answer your top pitch deck questions. What to expect in the overview & 20-minute Zoom session: How to answer investors' key questions Key slides to include in your pitch deck How to keep your pitch deck short, yet compelling  Schedule Office Hour
Read More

BIO Finance & Tax Committee Meeting
Share
October 5, 2023
The Committee concentrates on tax, financial services, securities, and accounting policies that impact member companies and biotech capital formation. This committee advises BIO staff about the impact of legislation and regulations affecting these policy matters and supports BIO’s engagement with Treasury, the SEC, and the IRS, as well as Congress and the Administration. For more information and to join the Committee, please contact Emily Berst (eberst@bio.org).
Read More

What's driving vaccine hesitancy?
Share
Good Day BIO Newsletter  •  October 5, 2023
A look at what’s driving vaccine hesitancy in this critical moment for several respiratory viruses—plus, new developments in CRISPR that could enable more efficient medical treatment delivery in living humans. (464 words, 2 minutes, 19 seconds)
Read More

BIO Office Hours: Pitching to Investors
Share
October 4, 2023
Sharing your company’s vision with potential investors or partners can be a critical factor in growing the company. A pitch deck is an essential tool for communicating your path to success. Ahead of the BIO Investor Forum (BIF) in October, business development expert, Linda Pullan from Pullan Consulting will be hosting twenty-minute virtual appointments to review and answer your top pitch deck questions. What to expect in the overview & 20-minute Zoom session: How to answer investors' key questions Key slides to include in your pitch deck How to keep your pitch deck short, yet compelling  Schedule Office Hour
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 77
  • 78
  • 79
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO